These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15987712)

  • 1. Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model.
    Delgado Alves J; Mason LJ; Ames PR; Chen PP; Rauch J; Levine JS; Subang R; Isenberg DA
    Rheumatology (Oxford); 2005 Oct; 44(10):1238-44. PubMed ID: 15987712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Persijn L; Decavele AS; Schouwers S; Devreese K
    Thromb Res; 2011 Dec; 128(6):565-9. PubMed ID: 21529896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular abnormalities, paraoxonase activity, and dysfunctional HDL in primary antiphospholipid syndrome.
    Charakida M; Besler C; Batuca JR; Sangle S; Marques S; Sousa M; Wang G; Tousoulis D; Delgado Alves J; Loukogeorgakis SP; Mackworth-Young C; D'Cruz D; Luscher T; Landmesser U; Deanfield JE
    JAMA; 2009 Sep; 302(11):1210-7. PubMed ID: 19755700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
    Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
    Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal IgG anticardiolipin antibodies induce nitric oxide synthase expression.
    Alves JD; Clapp BR; Stidwill R; Chen PP; Hingorani AD; Singer M; Isenberg DA
    Atherosclerosis; 2006 Apr; 185(2):246-53. PubMed ID: 16125710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I.
    Greco TP; Amos MD; Conti-Kelly AM; Naranjo JD; Ijdo JW
    Lupus; 2000; 9(1):33-41. PubMed ID: 10713645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma exchange and immunoadsorption effectively remove antiphospholipid antibodies in pregnant patients with antiphospholipid syndrome.
    Bontadi A; Ruffatti A; Marson P; Tison T; Tonello M; Hoxha A; De Silvestro G; Punzi L
    J Clin Apher; 2012; 27(4):200-4. PubMed ID: 22532158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies in HIV-positive patients.
    Galrão L; Brites C; Atta ML; Atta A; Lima I; Gonzalez F; Magalhães F; Santiago M
    Clin Rheumatol; 2007 Nov; 26(11):1825-30. PubMed ID: 17332976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
    Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
    Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome.
    Van Hoecke F; Persijn L; Decavele AS; Devreese K
    Int J Lab Hematol; 2012 Dec; 34(6):630-40. PubMed ID: 22827598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.